MIRA Pharmaceuticals (MIRA) Earnings Date & Reports
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MIRA is expected to report earnings to fall 31.91% to -15 cents per share on May 28
Q1'25
Est.
$-0.16
Q4'24
Missed
by $0.11
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.04
The last earnings report on February 26 showed earnings per share of -23 cents, missing the estimate of -12 cents. With 152.71K shares outstanding, the current market capitalization sits at 16.26M.